Seraph Enhances Board of Directors
This past month, Seraph seated Dr. Hür Koser on its Board of Directors. Dr. Koser has served as the company’s Chief Product & Technology Officer since last October. He brings over 17 years of experience as an academic researcher and technical entrepreneur in the diagnostics industry. “It is a privilege and an honor to continue to serve Seraph in this new capacity. I look forward to working with the esteemed board and management team”, said Dr. Koser. He replaces Dr. Richard Creager, who recently accepted the role of Chief Executive Officer for Seegene Technologies, a global developer of molecular technologies and multiplex assays. Seraph congratulates Dr. Koser and Dr. Creager on their new endeavors!